Latest Breaking News On - ப்ரொஃபெஸர் க்லெஂட சாம்பல் - Page 5 : comparemela.com
It s Time To Ease The Restrictions – Gray – iAfrica
iafrica.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from iafrica.com Daily Mail and Mail on Sunday newspapers.
South Africans urged to report vaccine side-effects as Sahpra probes 28 deaths
jacarandafm.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jacarandafm.com Daily Mail and Mail on Sunday newspapers.
é
syndrome have been reported following vaccination with the J&J single-dose vaccine.
There have, however, been only around 100 cases reported out of close to 13 million people receiving the jab in the US.
In SA s Sisonke trial, there was one reported case of the disorder among nearly 500 000 healthcare workers – and the patient recovered.
The Covid-19 vaccine by Johnson & Johnson (J&J) has been linked to a small increased risk of Guillain-Barré syndrome, a rare but potentially serious neurological condition, federal officials in the US said on Monday.
As a result, the US Food and Drug Administration (FDA) plans to add a warning about the syndrome to the J&J vaccine, as reported by
Everything we know so far about COVID boosters
msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.
Last Updated:
COVID-19: Pfizer Jab Prevents Severe Illness In Israel As Delta Variant Spreads
Pfizer Inc’s COVID-19 vaccine was showing less efficacy in protecting people in Israel against the Delta variant but continues to prevent severe illnesses.
IMAGE: AP/PTI
Pfizer Inc’s COVID-19 vaccine was showing less efficacy in protecting people in Israel against the Delta variant of coronavirus in recent weeks but the government data has reportedly revealed that the jab continues to provide a strong shield against severe illness. As per a Bloomberg report, the Pfizer shot protected 64% of people in Israel against severe COVID-19 between June 6 and early July. The drop was observed from 94% as delta variant continues to spread in the country, said the Israeli Health Ministry. Further, the number of people safeguarded against severe disease also plunged because it coincided with the easing of coronavirus restrictions that were introduced at the start of June.